Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke "STEMTHER"

Completed

Phase 2 Results N/A

Summary of Purpose

The aim of the study is to investigate treatment with Leukostim (Filgrastim; granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 January 2014.

1 Jun 2007 12 May 2009 1 Feb 2009 1 Feb 2009 1 Jan 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available